Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
EV/Core EBITDA

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

ASTRAZENECA PHARMA INDIA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 71.2158.3639.8458.8548.37

What is the latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA ?

The latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA is 71.21 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202571.21
Mar202458.36
Mar202339.84
Mar202258.85
Mar202148.37

How is EV/Core EBITDA of ASTRAZENECA PHARMA INDIA Trending?

Years EV/Core EBITDA % Change
Mar2025 71.21
22.02
Mar2024 58.36
46.49
Mar2023 39.84
-32.30
Mar2022 58.85
21.67
Mar2021 48.37 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare EV/Core EBITDA ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹22,386.3 Cr 3.2% 7.5% 15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

3.2%

7.5%

15.6%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses